Integra LifeSciences to Present at the Deutsche Bank 35th Annual Health Care, Bank of America Merrill Lynch Health Care and Citi Investment Research's 2010 Global Healthcare Conferences in May
PLAINSBORO, N.J., April 27, 2010 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today that it will present at three conferences in May.
On Monday, May 3th, 2010 at 11:20 am ET, Mr. Gerry Carlozzi, Executive Vice President and Chief Operating Officer of Integra, will present at the Deutsche Bank 35th Annual Health Care Conference at the InterContinental Hotel in Boston. There will be no webcast for this conference.
On Tuesday, May 11th, 2010 at 11:20 am ET, Mr. Gerry Carlozzi will present at Bank of America Merrill Lynch Health Care Conference at the Grand Hyatt in New York City. There will be a live audio webcast for this conference, a link will be available on the investor relations section on our corporate website -- www.integra-LS.com. This webcast will be archived after the live event.
On Thursday, May 27th, 2010 at 10:00 am ET, Mr. Gerry Carlozzi will present at Citi Investment Research's 2010 Global Healthcare Conference at the New York Hilton. There will be no webcast for this conference.
Integra LifeSciences Holdings Corporation, a world leader in regenerative medicine, is a global medical device company dedicated to improving the quality of life for millions of patients every year. Our products are used primarily in orthopedics, neurosurgery and general surgery. Headquartered in Plainsboro, New Jersey, Integra has research and manufacturing facilities throughout the world. For more information, visit www.Integra-LS.com.
Statements made at the upcoming conferences may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ from predicted results. Forward-looking factors that may be discussed include, but are not limited to, future financial performance, new product development, governmental approvals, market potential and resulting sales as well as potential therapeutic applications, and additional acquisitions. These risks and uncertainties include market conditions and other factors beyond the Company's control and the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in item IA of Integra's Annual Report on Form 10-K for the year ended December 31, 2009 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results. These forward-looking statements are made only as the date thereof, and the Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.
IART-G
CONTACT: Integra LifeSciences Holdings Corp.
John B. Henneman, III, Executive Vice President,
Finance and Administration and
Chief Financial Officer
(609) 275-0500
jhenneman@Integra-LS.com
Investor Relations:
Angela Steinway
(609) 936-2268
angela.steinway@Integra-LS.com(C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.